Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT03703297
Brief Title: Study of Durvalumab + Tremelimumab, Durvalumab, and Placebo in Limited Stage Small-Cell Lung Cancer in Patients Who Have Not Progressed Following Concurrent Chemoradiation Therapy (ADRIATIC)

First Submitted : September 19, 2018
First Submitted that Met QC Criteria : October 10, 2018
First Posted : October 11, 2018

Last Update Submitted that Met QC Criteria : September 16, 2021
Last Update Posted : September 17, 2021